{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:52:15Z","timestamp":1780087935409,"version":"3.54.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:00:00Z","timestamp":1494633600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11912-017-0604-7","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T01:29:43Z","timestamp":1494638983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pediatric Gynecologic Cancers"],"prefix":"10.1007","volume":"19","author":[{"given":"Lauren","family":"Pommert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,13]]},"reference":[{"issue":"Suppl 2","key":"604_CR1","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/MPH.0b013e31824e3867","volume":"34","author":"KAP Schultz","year":"2012","unstructured":"Schultz KAP, Schneider DT, Pashankar F, Ross J, Frazier L. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S55\u201363.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"604_CR2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejca.2014.11.013","volume":"51","author":"DT Schneider","year":"2015","unstructured":"\u2022\u2022 Schneider DT, Orbach D, Cecchetto G, Stachowicz-Stencel T, Brummel B, Brecht IB, et al. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Eur J Cancer. 2015;51(4):543\u201350. Sertoli-Leydig cell tumors can be risk stratified by stage and histopathologic differentiation. Patients with stage IA disease can be monitored with postoperative surveillance while those with stage IC and higher should be treated with adjuvant chemotherapy.","journal-title":"Eur J Cancer"},{"issue":"1","key":"604_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13193-012-0201-z","volume":"4","author":"VD Kottarathil","year":"2013","unstructured":"Kottarathil VD, Antony MA, Nair IR, Pavithran K. Recent advances in granulosa cell tumor ovary: a review. Indian J Surg Oncol. 2013;4(1):37\u201347.","journal-title":"Indian J Surg Oncol"},{"issue":"5","key":"604_CR4","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.jpag.2008.08.001","volume":"22","author":"S Sivasankaran","year":"2009","unstructured":"Sivasankaran S, Itam P, Ayensu-Coker L, Sanchez J, Egler RA, Anderson ML, et al. Juvenile granulosa cell ovarian tumor: a case report and review of literature. J Pediatr Adolesc Gynecol. 2009;22(5):e114\u20137.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"604_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00428-003-0869-0","volume":"443","author":"DT Schneider","year":"2003","unstructured":"Schneider DT, Janig U, Calaminus G, Gobel U, Harms D. Ovarian sex cord-stromal tumors\u2014a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry. Virchows Arch. 2003;443(4):549\u201360.","journal-title":"Virchows Arch"},{"issue":"1","key":"604_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/OGX.0000000000000010","volume":"69","author":"JE Stine","year":"2014","unstructured":"Stine JE, Pierce S, Soper JT. A comprehensive review of diagnostic and treatment options for granulosa cell tumors of the ovary. Obstet Gynecol Surv. 2014;69(1):29\u201338.","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"604_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/gyno.1997.4695","volume":"65","author":"G Calaminus","year":"1997","unstructured":"Calaminus G, Wessalowski R, Harms D, Gobel U. Juvenile granulosa cell tumors of the ovary in children and adolescents: results from 33 patients registered in a prospective cooperative study. Gynecol Oncol. 1997;65(3):447\u201352.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"604_CR8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/gyno.1996.4563","volume":"64","author":"JL Powell","year":"1997","unstructured":"Powell JL, Otis CN. Management of advanced juvenile granulosa cell tumor of the ovary. Gynecol Oncol. 1997;64(2):282\u20134.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"604_CR9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1210\/jc.2005-2710","volume":"91","author":"N Kalfa","year":"2006","unstructured":"Kalfa N, Ecochard A, Patte C, Duvillard P, Audran F, Pienkowski C, et al. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? Journal of Clinical Endocrinology & Metabolism. 2006;91(5):1842\u20137.","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"604_CR10","first-page":"187","volume":"21","author":"SL Ala-Fossi","year":"2000","unstructured":"Ala-Fossi SL, Aine R, Punnonen R, Maenpaa J. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors? Eur J Gynaecol Oncol. 2000;21(2):187\u20139.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"604_CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/gyno.1993.1019","volume":"48","author":"JL Powell","year":"1993","unstructured":"Powell JL, Johnson NA, Bailey CL, Otis CN. Management of advanced juvenile granulosa cell tumor of the ovary. Gynecol Oncol. 1993;48(1):119\u201323.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"604_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043426-200203000-00015","volume":"24","author":"A Erdreich-Epstein","year":"2002","unstructured":"Erdreich-Epstein A, Monforte HL, Lavey RS, Joshi S, Phillips JD, Villablanca JG. Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary. J Pediatr Hematol Oncol. 2002;24(3):229\u201333.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"604_CR13","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1097\/MPH.0000000000000387","volume":"37","author":"M Benesch","year":"2015","unstructured":"Benesch M, Lackner H, Pilhatsch A, Gurtl-Lackner B, Schwinger W, Urban C. Long-term remission in a female with multiple relapsed juvenile granulosa cell tumor. J Pediatr Hematol Oncol. 2015;37(8):e486\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"604_CR14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/pbc.22918","volume":"56","author":"G Cecchetto","year":"2011","unstructured":"Cecchetto G, Ferrari A, Bernini G, Alaggio R, Collini P, Virgone C, et al. Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project. Pediatr Blood Cancer. 2011;56(7):1062\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"604_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5468\/ogs.2013.56.3.198","volume":"56","author":"S Lim","year":"2013","unstructured":"Lim S, Kim N, Lee K. A case of successful salvage chemotherapy of recurrent ovarian sertoli-leydig cell tumor. Obstet gynecol sci. 2013;56(3):198\u2013200.","journal-title":"Obstet gynecol sci"},{"issue":"1","key":"604_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00404-007-0503-5","volume":"278","author":"F Ghaemmaghami","year":"2008","unstructured":"Ghaemmaghami F, Karimi Zarchi M, Ghasemi M. Lower genital tract rhabdomyosarcoma: case series and literature review. Arch Gynecol Obstet. 2008;278(1):65\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"604_CR17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ygyno.2005.08.048","volume":"99","author":"JA Villella","year":"2005","unstructured":"Villella JA, Bogner PN, Jani-Sait SN, Block AMW, Lele S. Rhabdomyosarcoma of the cervix in sisters with review of the literature. Gynecol Oncol. 2005;99(3):742\u20138.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"604_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0899-7071(00)00222-9","volume":"24","author":"EE Kim","year":"2000","unstructured":"Kim EE, Valenzuela RF, Kumar AJ, Raney RB, Eftekari F. Imaging and clinical spectrum of rhabdomyosarcoma in children. Clin Imaging. 2000;24(5):257\u201362.","journal-title":"Clin Imaging"},{"issue":"1","key":"604_CR19","doi-asserted-by":"crossref","first-page":"e006030","DOI":"10.1136\/bmjopen-2014-006030","volume":"5","author":"G Norman","year":"2015","unstructured":"Norman G, Fayter D, Lewis-Light K, Chisholm J, McHugh K, Levine D, et al. An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review. BMJ Open. 2015;5(1):e006030.","journal-title":"BMJ Open"},{"issue":"3","key":"604_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e3282f8b053","volume":"20","author":"TW McLean","year":"2008","unstructured":"McLean TW, Castellino SM. Pediatric genitourinary tumors. Curr Opin Oncol. 2008;20(3):315\u201320.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"604_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.urolonc.2015.09.013","volume":"34","author":"M Harel","year":"2016","unstructured":"\u2022\u2022 Harel M, Ferrer FA, Shapiro LH, Makari JH. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma. Urol Oncol. 2016;34(2):103\u201315. Alveolar rhabdomyosarcomas with fusions proetins caused by translocations t(2;13) and t(1;13) are known to be more aggressive in nature and future studies will likely incorporate this fusion status into risk stratification.","journal-title":"Urol Oncol"},{"issue":"3","key":"604_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","volume":"233","author":"WD Foulkes","year":"2014","unstructured":"Foulkes WD, Clarke BA, Hasselblatt M, Majewski J, Albrecht S, McCluggage WG. No small surprise\u2014small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. J Pathol. 2014;233(3):209\u201314.","journal-title":"J Pathol"},{"issue":"7","key":"604_CR23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/0022-3468(95)90336-4","volume":"30","author":"RJ Andrassy","year":"1995","unstructured":"Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W, Lobe TE, et al. Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg. 1995;30(7):1034\u20136. discussion 1036-7","journal-title":"J Pediatr Surg"},{"issue":"5","key":"604_CR24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3468(99)90365-2","volume":"34","author":"RJ Andrassy","year":"1999","unstructured":"Andrassy RJ, Wiener ES, Raney RB, Hays DM, Arndt CA, Lobe TE, et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg. 1999;34(5):731\u20134. discussion 734-5","journal-title":"J Pediatr Surg"},{"issue":"12","key":"604_CR25","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/1097-0142(20010615)91:12<2454::AID-CNCR1281>3.0.CO;2-C","volume":"91","author":"CA Arndt","year":"2001","unstructured":"Arndt CA, Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer. 2001;91(12):2454\u201368.","journal-title":"Cancer"},{"issue":"7","key":"604_CR26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jpedsurg.2014.03.018","volume":"49","author":"G Lambert de","year":"2014","unstructured":"de Lambert G, Haie-Meder C, Guerin F, Boubnova J, Martelli H. A new surgical approach of temporary ovarian transposition for children undergoing brachytherapy: technical assessment and dose evaluation. J Pediatr Surg. 2014;49(7):1177\u201380.","journal-title":"J Pediatr Surg"},{"issue":"18","key":"604_CR27","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","volume":"115","author":"S Ognjanovic","year":"2009","unstructured":"Ognjanovic S, Linabery AM, Charbonneau B, Ross JA. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009;115(18):4218\u201326.","journal-title":"Cancer"},{"issue":"11","key":"604_CR28","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1200\/JCO.1999.17.11.3487","volume":"17","author":"AS Pappo","year":"1999","unstructured":"Pappo AS, Anderson JR, Crist WM, Wharam MD, Breitfeld PP, Hawkins D, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17(11):3487\u201393.","journal-title":"J Clin Oncol"},{"issue":"1","key":"604_CR29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/pbc.21482","volume":"51","author":"R Vasquez","year":"2008","unstructured":"Vasquez R, Collini P, Meazza C, Favini F, Casanova M, Ferrari A. Late relapse of embryonal rhabdomyosarcoma, botryoid variant, of the vagina. Pediatr Blood Cancer. 2008;51(1):140\u20131.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"604_CR30","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/MPH.0b013e31825802c2","volume":"35","author":"BA Mixon","year":"2013","unstructured":"Mixon BA, Eckrich MJ, Lowas S, Engel ME. Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma. J Pediatr Hematol Oncol. 2013;35(4):e163\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"604_CR31","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/pbc.25622","volume":"62","author":"S Winter","year":"2015","unstructured":"Winter S, Fasola S, Brisse H, Mosseri V, Orbach D. Relapse after localized rhabdomyosarcoma: evaluation of the efficacy of second-line chemotherapy. Pediatr Blood Cancer. 2015;62(11):1935\u201341.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"604_CR32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MPH.0000000000000125","volume":"36","author":"CH Mosbech","year":"2014","unstructured":"Mosbech CH, Rechnitzer C, Brok JS, Rajpert-De Meyts E, Hoei-Hansen CE. Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors. J Pediatr Hematol Oncol. 2014;36(4):263\u201370.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"20","key":"604_CR33","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1002\/cncr.25454","volume":"116","author":"JN Poynter","year":"2010","unstructured":"Poynter JN, Amatruda JF, Ross JA. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer. 2010;116(20):4882\u201391.","journal-title":"Cancer"},{"key":"604_CR34","first-page":"1116","volume-title":"Principles and practice of pediatric oncology","author":"B Cushing","year":"2006","unstructured":"Cushing B, Perlman EJ, Marina NM, Castleberry RP. Germ cell tumors. In: Pizzo P, Poplack D, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott, Williams and Wilkins; 2006. p. 1116\u201338.","edition":"5th"},{"issue":"2","key":"604_CR35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.29732","volume":"122","author":"F Pashankar","year":"2016","unstructured":"\u2022\u2022 Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122(2):230\u20137. Pooled analysis of pediatric and adult patients with ovarian immature teratomas revealed that grade is the most important risk factor for disease relapse and adjuvant chemotherapy did not decrease the relapse risk in the pediatric cohort.","journal-title":"Cancer"},{"key":"604_CR36","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Mangili G, Sigismondi C, Lorusso D, Cormio G, Candiani M, Scarfone G, et al. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study. Ann Oncol. 2017 Feb 1;28(2):333\u2013338. A large retrospective review in adults with stage I dysgerminoma and immature teratoma found that reserving adjuvant chemotherapy for patients with relapsed disease resulted in high cure rates and spared many patients the morbidity and mortality associated with chemotherapy. Those patients with yolk sac histology had worse prognosis.","DOI":"10.1093\/annonc\/mdw563"},{"issue":"2","key":"604_CR37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2016.08.329","volume":"143","author":"DM Gershenson","year":"2016","unstructured":"Gershenson DM, Frazier AL. Conundrums in the management of malignant ovarian germ cell tumors: toward lessening acute morbidity and late effects of treatment. Gynecol Oncol. 2016;143(2):428\u201332.","journal-title":"Gynecol Oncol"},{"issue":"27","key":"604_CR38","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.2014.60.5337","volume":"33","author":"TA Olson","year":"2015","unstructured":"Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, et al. Pediatric and adolescent extracranial germ cell tumors: the road to collaboration. J Clin Oncol. 2015;33(27):3018\u201328.","journal-title":"J Clin Oncol"},{"issue":"5","key":"604_CR39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2013.51.1006","volume":"32","author":"DF Billmire","year":"2014","unstructured":"\u2022\u2022 Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol. 2014;32(5):465\u201370. Pediatric patients with stage I malignant ovarian germ cell tumor can be monitored after surgery with surveillance alone. Chemotherapy treatment can be reserved for patients who have recurrent disease and overall survival remains preserved.","journal-title":"J Clin Oncol"},{"issue":"3","key":"604_CR40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0959-8049(99)00317-2","volume":"36","author":"MC Baranzelli","year":"2000","unstructured":"Baranzelli MC, Bouffet E, Quintana E, Portas M, Thyss A, Patte C. Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer. 2000;36(3):376\u201383.","journal-title":"Eur J Cancer"},{"issue":"22","key":"604_CR41","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2000.18.22.3809","volume":"18","author":"JR Mann","year":"2000","unstructured":"Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, et al. The United Kingdom Children's Cancer Study Group\u2019s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 2000;18(22):3809\u201318.","journal-title":"J Clin Oncol"},{"issue":"7","key":"604_CR42","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626\u201336.","journal-title":"Int J Cancer"},{"issue":"26","key":"604_CR43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","volume":"65","author":"LJ Viens","year":"2016","unstructured":"Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus-associated cancers\u2014United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"604_CR44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/ciw533","volume":"63","author":"JA Kahn","year":"2016","unstructured":"Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, et al. Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community. Clin Infect Dis. 2016;63(10):1281\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"604_CR45","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s11606-016-3725-z","volume":"31","author":"M McNamara","year":"2016","unstructured":"McNamara M, Batur P, Walsh JME, Johnson KM. HPV update: vaccination, screening, and associated disease. J Gen Intern Med. 2016;31(11):1360\u20136.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"604_CR46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet M, Benard E, Boily M, Ali H, Baandrup L, Bauer H, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565\u201380.","journal-title":"Lancet Infect Dis"},{"issue":"29","key":"604_CR47","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","volume":"64","author":"S Reagan-Steiner","year":"2015","unstructured":"Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(29):784\u201392.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"604_CR48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","volume":"168","author":"DM Holman","year":"2014","unstructured":"Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76\u201382.","journal-title":"JAMA Pediatr"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-017-0604-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-017-0604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-017-0604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:04:30Z","timestamp":1569326670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-017-0604-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,13]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s11912-017-0604-7","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,13]]},"article-number":"44"}}